{"identifier":"nobleid:/w1/20260521/C503C184","arkIdentifier":"ark:/48914/w1/20260521/C503C184","version":1,"workTitle":"Comparison of kidney cancer symptoms and quality of life (QoL) in renal cell cancer (RCC) patients (pts) receiving sorafenib vs interferon-α (IFN)","workType":"Journal Article","authors":"Cezary Szczylik, David Cella, Tim Eisen, Sumit Shah, Nicole Laferriere, Urban Scheuring, B. Escudier","description":null,"workUrl":null,"existingDoi":"10.1200/jco.2008.26.15_suppl.9603","createdAt":"2026-05-21T21:45:30.010566Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260521/C503C184.v1"}